Brief: Dimerix Ltd Receives Regulatory Approval To Expand Action3 Phase 3 Fsgs Kidney Trial Into Malaysia
22/09/2023 24:16
Sept 22 (Reuters) - Dimerix Ltd DXB.AX :
* RECEIVES REGULATORY APPROVAL TO EXPAND ACTION3 PHASE 3
FSGS
KIDNEY TRIAL INTO MALAYSIA
Source text for Eikon: ID:nASXbXjkx9
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions